Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters
Database
Language
Document Type
Year range
1.
Covid-19 will not "magically disappear": Why access to widespread testing is paramount.
George, Paul E; Stokes, Claire L; Bassit, Leda C; Chahroudi, Ann; Figueroa, Janet; Griffiths, Mark A; Heilman, Stacy; Ku, David N; Nehl, Eric J; Leong, Traci; Levy, Joshua M; Kempker, Russell; Mannino, Robert G; Mavigner, Maud; Park, Sunita I; Rao, Anuradha; Rebolledo, Paulina A; Roback, John D; Rogers, Beverly B; Schinazi, Raymond F; Sullivan, Julie; Tyburski, Erika A; Vos, Miriam B; Waggoner, Jesse J; Wang, Yun F; Madsen, Jen; Wechsler, Daniel S; Joiner, Clinton H; Martin, Greg S; Lam, Wilbur A.
Am J Hematol ; 96(2): 174-178, 2021 02 01.
Article in English | MEDLINE | ID: covidwho-954382

Subject(s)
COVID-19 Testing , COVID-19/diagnosis , Health Services Accessibility , Pandemics , SARS-CoV-2/isolation & purification , Antigens, Viral/analysis , Antigens, Viral/immunology , COVID-19/epidemiology , COVID-19 Nucleic Acid Testing , COVID-19 Testing/economics , COVID-19 Testing/methods , COVID-19 Testing/statistics & numerical data , Coronavirus Nucleocapsid Proteins/analysis , Coronavirus Nucleocapsid Proteins/immunology , Cost-Benefit Analysis , Evaluation Studies as Topic , Financing, Government , Humans , Inventions , National Institutes of Health (U.S.) , Point-of-Care Testing , Public-Private Sector Partnerships/organization & administration , RNA, Viral/analysis , Reagent Kits, Diagnostic/supply & distribution , SARS-CoV-2/immunology , Sensitivity and Specificity , Spike Glycoprotein, Coronavirus/analysis , Spike Glycoprotein, Coronavirus/immunology , United States/epidemiology
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL